Insights: Results
Initial Data Shows that PTAB Is Not a ῾Death Squadʼ for Biologic Drug Patents
by Corinne E. Atton and April M. Breyer
The March 2017 statistics issued by PTAB report that across all technologies, all challenged patent claims are found patentable in only 19 percent of inter partes review (IPR) final written decisions.
IN PARTNERSHIP
Embedded Advantage: The Value in Partnering with Appellate Counsel
by Justin Smulison
Most litigants should expect the non-prevailing party in their case to challenge the trial court’s final judgment in post-judgment motions and/or on appeal. Robert A. Mandel discusses how aligning with a seasoned appellate lawyer can make all the difference in securing a favorable resolution.
Sorry, no results were found.
Suggestions:
- Check your spelling.
- Try more general words.
- Try a different word with the same meaning.